EMAIL THIS PAGE TO A FRIEND

PloS one

Contribution of Schwann Cells to Remyelination in a Naturally Occurring Canine Model of CNS Neuroinflammation.


PMID 26196511

Abstract

Gliogenesis under pathophysiological conditions is of particular clinical relevance since it may provide evidence for regeneration promoting cells recruitable for therapeutic purposes. There is evidence that neurotrophin receptor p75 (p75NTR)-expressing cells emerge in the lesioned CNS. However, the phenotype and identity of these cells, and signals triggering their in situ generation under normal conditions and certain pathological situations has remained enigmatic. In the present study, we used a spontaneous, idiopathic and inflammatory CNS condition in dogs with prominent lympho-histiocytic infiltration as a model to study the phenotype of Schwann cells and their relation to Schwann cell remyelination within the CNS. Furthermore, the phenotype of p75NTR-expressing cells within the injured CNS was compared to their counter-part in control sciatic nerve and after peripheral nerve injury. In addition, organotypic slice cultures were used to further elucidate the origin of p75NTR-positive cells. In cerebral and cerebellar white and grey matter lesions as well as in the brain stem, p75NTR-positive cells co-expressed the transcription factor Sox2, but not GAP-43, GFAP, Egr2/Krox20, periaxin and PDGFR-α. Interestingly, and contrary to the findings in control sciatic nerves, p75NTR-expressing cells only co-localized with Sox2 in degenerative neuropathy, thus suggesting that such cells might represent dedifferentiated Schwann cells both in the injured CNS and PNS. Moreover, effective Schwann cell remyelination represented by periaxin- and P0-positive mature myelinating Schwann cells, was strikingly associated with the presence of p75NTR/Sox2-expressing Schwann cells. Intriguingly, the emergence of dedifferentiated Schwann cells was not affected by astrocytes, and a macrophage-dominated inflammatory response provided an adequate environment for Schwann cells plasticity within the injured CNS. Furthermore, axonal damage was reduced in brain stem areas with p75NTR/Sox2-positive cells. This study provides novel insights into the involvement of Schwann cells in CNS remyelination under natural occurring CNS inflammation. Targeting p75NTR/Sox2-expressing Schwann cells to enhance their differentiation into competent remyelinating cells appears to be a promising therapeutic approach for inflammatory/demyelinating CNS diseases.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

259527
1,2-Dimethoxyethane, anhydrous, 99.5%, inhibitor-free
C4H10O2
MAB348
Anti-APP A4 Antibody, a.a. 66-81 of APP {NT}, clone 22C11, 50 µg, Anti-APP A4 Antibody, a.a. 66-81 of APP {N-terminus}, clone 22C11 is an antibody against Alzheimer Precursor Protein A4 for use in IF, IH, IH(P) & WB with more than 85 product citations.
AB5220
Anti-Growth Associated Protein-43 (GAP-43) Antibody, 100 µL, Anti-Growth Associated Protein-43 (GAP-43) Antibody is an antibody against Growth Associated Protein-43 (GAP-43) for use in ELISA, IC, IH, IP & WB.
SAB2500343
Anti-EGR2 antibody produced in goat, affinity isolated antibody, buffered aqueous solution
SAB1405747
Anti-EGR2 antibody produced in mouse, purified immunoglobulin, buffered aqueous solution
SAB1408966
Anti-EGR2 antibody produced in mouse, purified immunoglobulin, buffered aqueous solution
AV100880
Anti-EGR2 antibody produced in rabbit, affinity isolated antibody
SAB1410324
Anti-EGR2 antibody produced in rabbit, purified immunoglobulin, buffered aqueous solution
HPA001868
Anti-PRX antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
L3759 Lectin from Bandeiraea simplicifolia (Griffonia simplicifolia), biotin conjugate, lyophilized powder
SAB1402178
Monoclonal Anti-EGR2 antibody produced in mouse, clone 1G5, purified immunoglobulin, buffered aqueous solution
P6061
Phenylacetic acid, plant cell culture tested
C8H8O2
P16621
Phenylacetic acid, 99%
C8H8O2
W287814
Phenylacetic acid, natural, ≥99%
C8H8O2
W287806
Phenylacetic acid, ≥99%, FCC, FG
C8H8O2
R4505 Rabbit Serum, USDA approved origin, sterile-filtered, suitable for cell culture